Conmed Corp.’s recent filing unveils that its Officer Peters Stanley W III acquired Company’s shares for reported $0.16 million on Aug 27 ’24. In the deal valued at $72.40 per share,2,171 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Peters Stanley W III sold 4,000 shares, generating $287,280 in total proceeds. Upon selling the shares at $71.82, the President AS and AET now owns 63 shares.
Before that, BRONSON DAVID M bought 1,350 shares. Conmed Corp. shares valued at $97,322 were divested by the Director at a price of $72.09 per share. As a result of the transaction, BRONSON DAVID M now holds 16,460 shares, worth roughly $1.05 million.
Needham reiterated its Conmed Corp. [CNMD] rating to a Buy in a research note published on February 01, 2024; the price target was $129. A number of analysts have revised their coverage, including CL King’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. KeyBanc Capital Markets also remained covering CNMD and has increased its forecast on March 27, 2023 with a “an Overweight” recommendation from previously “Sector weight” rating. Wells Fargo started covering the stock on March 21, 2023. It rated CNMD as “an Equal weight”.
Price Performance Review of CNMD
On Monday, Conmed Corp. [NYSE:CNMD] saw its stock fall -3.81% to $64.05. Over the last five days, the stock has lost -10.94%. Conmed Corp. shares have fallen nearly -41.51% since the year began. Nevertheless, the stocks have fallen -33.74% over the past one year. While a 52-week high of $117.27 was reached on 01/12/24, a 52-week low of $61.05 was recorded on 04/25/24. SMA at 50 days reached $70.63, while 200 days put it at $78.31.
Levels Of Support And Resistance For CNMD Stock
The 24-hour chart illustrates a support level at 62.94, which if violated will result in even more drops to 61.82. On the upside, there is a resistance level at 65.79. A further resistance level may holdings at 67.52. The Relative Strength Index (RSI) on the 14-day chart is 29.71, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.48%. Stochastics %K at 4.51% indicates the stock is a buying.
How much short interest is there in Conmed Corp.?
A steep rise in short interest was recorded in Conmed Corp. stocks on 2024-09-13, dropping by -0.15 million shares to a total of 3.04 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 3.19 million shares. There was a decline of -4.91%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 12, 2022 when Jefferies began covering the stock and recommended ‘”a Hold”‘ rating along with a $85 price target.
